Current Report Filed: 2026-05-01

Key Insights

  • Significant dilution structure: Exchange of 19.6M securities (shares, options, warrants) for 1.96M Series C Preferred shares represents a major restructuring that grants Series C holders 59.6% ownership upon a qualified financing of $15M+, heavily favoring existing insiders and officers.
  • Super-voting preferred shares: Series C Preferred holders receive 40 votes per share versus common stock's 1 vote, creating substantial control concentration that may limit minority shareholders' influence over future company decisions.
  • Conditional conversion mechanics: If no qualified financing occurs by March 31, 2028, Series C shares convert to 10 common shares each, creating binary outcome scenarios that could dramatically impact share count and ownership percentages within 2 years.
  • Insider participation: Officers and directors are among the Exchange Holders, raising potential governance concerns about related-party transaction fairness despite the use of Section 4(a)(2) exemption from registration.
Current Report Filed: 2026-02-18

Key Insights

  • Biotricity Inc. announced its financial results for the period ended December 31, 2025, indicating the company's performance during that quarter.
  • The filing does not provide any details on the company's revenue, margins, or financial guidance, limiting the insights that can be gleaned.
  • Without further details on the company's operational and financial performance, the significance of this filing is limited for investors.
Quarterly Report Filed: 2026-02-11

Key Insights

  • The company's revenue from device sales and technology fees has shown steady growth over the past year, indicating strong demand for its products.
  • The company has taken on additional debt financing through a new convertible note, which could provide capital to fund future operations and growth.
  • The company has seen an increase in its Series B convertible redeemable preferred stock, which may indicate investor interest and confidence in the company's prospects.

Filings on this page are at least 90 days old. In the app, any new Biotricity Inc. filing is analysed the moment you open it.

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.